BetterLife Pharma Inc. (BETRF)
OTCMKTS · Delayed Price · Currency is USD
0.0455
-0.0013 (-2.78%)
At close: Mar 26, 2026
BetterLife Pharma Market Cap
BetterLife Pharma has a market cap or net worth of $6.91 million as of March 26, 2026. Its market cap has decreased by -36.63% in one year.
Market Cap
6.91M
Enterprise Value
9.80M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since October 4, 2010, BetterLife Pharma's market cap has decreased from 98.33M to 6.91M, a decrease of -92.97%. That is a compound annual growth rate of -15.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 6.91M | 40.87% |
| Dec 31, 2025 | 4.91M | -47.43% |
| Dec 31, 2024 | 9.33M | 68.00% |
| Dec 29, 2023 | 5.55M | -49.28% |
| Dec 30, 2022 | 10.95M | -24.42% |
| Dec 31, 2021 | 14.49M | -81.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 9.82M |
| Synlogic | 8.20M |
| TRON Group | 8.18M |
| NKGen Biotech | 7.84M |
| AccuStem Sciences | 7.71M |
| Nymox Pharmaceutical | 7.19M |
| Bioxytran | 6.53M |
| Mosaic ImmunoEngineering | 5.01M |